FDA CBER Patient Listening Meeting
When:
December 4, 2024 @ 11:00 am – 4:30 pm
America/New York Timezone
2024-12-04T11:00:00-05:00
2024-12-04T16:30:00-05:00
Where:
Virtual Meeting
Contact:
On Wednesday, December 4 from 11:00 a.m. – 4:30 p.m. ET., the Rett community is invited to join the FDA Center for Biologics Evaluation and Research (CBER) for a public patient listening meeting to better understand patient and care partner perspectives on enrollment into gene therapy clinical trials. The objective of this meeting is to understand what caregivers of patients in the pre-symptomatic or early stages of disease take into consideration when deciding whether to enroll in a gene therapy clinical trial and potentially receive an investigational gene therapy product. This meeting is free and open to the public; however, registration is required.